Blog

  • Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Shinkwin on 2016-03-17.

    To ask Her Majesty’s Government what steps they are taking to support individuals with Down’s Syndrome and their families.

    Lord Prior of Brampton

    There is support available for families with children born with Down’s syndrome. For many people this will involve an early intervention programme, to help support the child’s development and provide support to the family. This support will be delivered by health visitors and midwives.

    An early intervention programme can include speech and language therapy, physiotherapy to help with any muscle weakness, and individual home teaching programmes.

    Where a child has a special educational need, the local authority should also make support available to ensure the child has access to the same educational opportunities as a child without such a need. The Children and Families Act 2014 introduced a statutory framework for local authorities and clinical commissioning groups (CCGs), to work together to secure services for children and young people up to the age of 25 who have special educational needs or disability.

    General practitioners can provide an annual learning disability health check. Children and young people aged 14 and over who are on a general practice’s learning disability register are eligible to have a health check and a health action plan linked to this check. The health check and health action plan can inform a local authority’s annual review of young people with special educational needs from age 14 onwards to help them to prepare for adult life.

    The Care Act 2014 requires local authorities to undertake an assessment when an adult appears to have care and support needs. The assessment must involve the adult, their carer and anyone else they want to involve and consider the outcomes the person wants to achieve, their needs and how these impact on their wellbeing.

  • Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Shinkwin on 2016-03-17.

    To ask Her Majesty’s Government how much has been invested in the last year in (1) Down’s Syndrome research, (2) Down’s Syndrome screening, and (3) support for people with Down’s Syndrome.

    Lord Prior of Brampton

    The information requested on total investment in Down’s syndrome research is not available. Spend on research funded directly by the National Institute for Health Research (NIHR) is categorised by Health Research Classification System (HRCS) health categories including ‘congenital disorders’. There are no HRCS health sub-categories, such as for Down’s syndrome or other specific syndromes.

    To obtain how much the National Health Service invested in Down’s syndrome screening in the last year would incur a disproportionate cost.

    Data on how much has been invested in the last year on support for people with Down’s syndrome is not held centrally.

  • Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Shinkwin on 2016-03-17.

    To ask Her Majesty’s Government what assessment they have made of the possible effects of normalising cell-free DNA, non-invasive prenatal testing techniques, in particular with regard to enabling sex-selective abortions.

    Lord Prior of Brampton

    There is a long established Fetal Anomaly Screening Programme (NHS FASP) that prospective parents can choose whether to participate in. The UK National Screening Committee recommendation on non-invasive prenatal testing (NIPT) does not change the choices available to prospective parents within the NHS FASP. Guidance from the Royal College of Obstetricians and Gynaecologists makes it clear that women and their partners should receive appropriate information and support from a properly trained multidisciplinary team, who must adopt a supportive and non-judgemental approach.

    NIPT testing as part of the NHS FASP will not be used to determine the sex of the foetus. Abortion on the grounds of gender alone is illegal.

  • Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Shinkwin on 2016-03-17.

    To ask Her Majesty’s Government what steps they are taking to fulfil their obligations under the UN Convention on the Rights of Persons with Disabilities, and in particular Article 23, subsection 3.

    Lord Prior of Brampton

    There is a long established Fetal Anomaly Screening Programme that prospective parents can choose whether to participate in. The United Kingdom National Screening Committee recommendation on non-invasive prenatal testing does not change the choices available to prospective parents within the programme. We are satisfied that the UK is compliant with its obligations under the United Nations Convention on the Rights of Persons with Disabilities and that the Programme is compliant with all obligations under the Equality Act 2010. We would also note that English law does not recognise a foetus as a separate legal person.

  • Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    Lord Shinkwin – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Shinkwin on 2016-03-17.

    To ask Her Majesty’s Government what action they are taking to ensure that the UK complies with its obligations under the UN Convention on the Rights of Persons with Disabilities if cell-free DNA, non-invasive prenatal testing techniques are made available to pregnant women on the NHS.

    Lord Prior of Brampton

    There is a long established Fetal Anomaly Screening Programme that prospective parents can choose whether to participate in. The United Kingdom National Screening Committee recommendation on non-invasive prenatal testing does not change the choices available to prospective parents within the programme. We are satisfied that the UK is compliant with its obligations under the United Nations Convention on the Rights of Persons with Disabilities and that the Programme is compliant with all obligations under the Equality Act 2010. We would also note that English law does not recognise a foetus as a separate legal person.

  • Lord Myners – 2016 Parliamentary Question to the HM Treasury

    Lord Myners – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Myners on 2016-03-17.

    To ask Her Majesty’s Government whether they intend to monitor the role of institutional investors in voting their clients’ shares regarding the potential takeover of the London Stock Exchange, in order to ensure that this reflects the best interests of the clients rather than the fund manager or related parties.

    Lord O’Neill of Gatley

    The regulatory framework governing asset managers requires managers to take all reasonable steps to identify, prevent, manage and monitor conflicts of interest.

    The Financial Conduct Authority are responsible for the supervision of firms to ensure consumers are protected and treated fairly.

  • Lord Myners – 2016 Parliamentary Question to the HM Treasury

    Lord Myners – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Myners on 2016-03-17.

    To ask Her Majesty’s Government whether they will review the possible consequences for financial stability of the consolidation of central clearing houses.

    Lord O’Neill of Gatley

    European Regulation No 648/2012 (EMIR) establishes a strict supervisory framework for CCPs, which in the UK are regulated by the Bank of England.

    EMIR’s requirements – which continue to apply in the event of a merger or change of control of a CCP – include that a CCP must be sufficiently well-resourced to withstand extreme market events, including the simultaneous default of its two largest clearing members.

    In the event of a qualifying change of control the Bank of England must under EMIR also assess the suitability of the proposed acquirer and financial soundness of the proposed acquisition.

    Copies of the Bank of England’s 2016 report on supervision of financial market infrastructures were laid before Parliament on 4 March and are available in the House library.

  • Lord Myners – 2016 Parliamentary Question to the HM Treasury

    Lord Myners – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Myners on 2016-03-17.

    To ask Her Majesty’s Government whether the Office for Budget Responsibility has produced its own forecast of the consequences of the UK leaving the EU.

    Lord O’Neill of Gatley

    The Office for Budget Responsibility (OBR) prepares its forecasts on the basis of the current Government policy and does not look at alternative policy scenarios. Government policy is to remain within the EU. Therefore the OBR has not factored into its forecast the impact of a UK exit from the EU.

  • Baroness Miller of Chilthorne Domer – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Miller of Chilthorne Domer – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Miller of Chilthorne Domer on 2016-03-17.

    To ask Her Majesty’s Government why their representatives in the International Court of Justice on 14 March requested the Court to declare that it lacked jurisdiction over the claim brought against the UK by the Marshall Islands, or that the claim is inadmissible, and under what circumstances they believe the International Court of Justice has jurisdiction.

    Baroness Anelay of St Johns

    The UK’s representatives requested the International Court of Justice (ICJ) to declare the case inadmissible because that was our assessment following our analysis of the Marshall Islands’ claim. The detail of the UK’s legal arguments is contained in its written preliminary objections to jurisdiction and admissibility, as filed with the Court on 15 June 2015 and oral pleadings, as delivered at the public hearings held at the Court between 9 and 16 March 2016. The question of whether the ICJ has jurisdiction in a particular set of circumstances is a matter to be determined by the Court on a case-by-case basis in light of the relevant facts.

  • Lord Mawhinney – 2016 Parliamentary Question to the Department of Health

    Lord Mawhinney – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mawhinney on 2016-03-17.

    To ask Her Majesty’s Government how information is (1) collected, and (2) managed, to protect the confidentiality of patients who receive pharmacy services in retail outlets, under Standards for registered pharmacies, Principle 1.

    Lord Prior of Brampton

    Pharmacy owners and superintendent pharmacists of bodies corporate are responsible for meeting the General Pharmaceutical Council’s standards for registered pharmacies and must decide how best to do so, including managing information to protect the privacy, dignity and confidentiality of patients and the public, within their pharmacies.

    There are a number of different ways in which pharmacy professionals and the wider pharmacy team may receive patient information. Information is included on prescriptions, or may be shared by patients when seeking care from a pharmacy. In addition, information may be stored in patient medication records or other records.

    Through its inspections, the General Pharmaceutical Council seeks assurance from the pharmacy team about how they maintain the confidentiality, privacy and dignity of patients and the public. These assurances can be provided through a number of different means, for example restricted password access to patient information, appropriate training of staff or making sure patients can have conversations with members of the pharmacy team in private.

    All National Health service providers, including community pharmacies, also need to provide information governance assurances to the NHS on an annual basis.